AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2020
Apr 24, 2020
29755_dirs_2020-04-24_d470be61-bfe9-4791-95ae-a6ade789037c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-03-18
Reporting Person: Durkin Brian L (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-20 | Common Stock, $0.01 par value | P | 1550 | $69 | Acquired | 17644 | Direct |
Footnotes
F1: This amendment is being filed to correctly indicate the number of shares purchased by the reporting person on March 20, 2020.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4